FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRÜHBECK, G.
Right arrow Articles by GÓMEZ-AMBROSI, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRÜHBECK, G.
Right arrow Articles by GÓMEZ-AMBROSI, J.
(The FASEB Journal. 2001;15:1996-2006.)
© 2001 FASEB

Rationale for the existence of additional adipostatic hormones

GEMA FRÜHBECK*,{dagger}1 and JAVIER GÓMEZ-AMBROSI*

* Metabolic Research Laboratory, University of Navarra; and
{dagger} Department of Endocrinology, Clínica Universitaria de Navarra, 31008-Pamplona, Spain

1Correspondence: Deptartment of Endocrinology, Clínica Universitaria de Navarra, 31008-Pamplona, Spain. E-mail: gfruhbeck{at}unav.es


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 
Parabiosis studies with obese rodents demonstrated that circulating factors are involved in the long-term control of food intake and energy balance. More than 40 years ago it was hypothesized that rats made obese by hypothalamic or dietary means, as well as genetically obese fa/fa rats and db/db mice, produce a circulating factor that either inhibits food intake or acts metabolically to reduce the fat content of non-obese ad libitum-fed partners. However, none of these obese rodents showed a significant change in weight when parabiosed to a normal animal. It was therefore postulated that these obese rodents produced a circulating lipostatic factor but were unable to respond to it. In contrast, genetically obese ob/ob mice were thought to be deficient in the circulating signal, as they lost weight when parabiosed to lean or obese db/db mice. The discovery of leptin suggested that the circulating lipostatic signal had been identified. However, a closer look at the outcome of the parabiotic studies reveals that leptin alone does not explain all of the findings of the parabiotic experiments. Another (or more than one) as yet unidentified factor(s) may be involved in energy balance regulation. The evidence for the existence of further leptin-like hormones comes from observations in which the direct effect of leptin has been eliminated or can be excluded.—Frühbeck, G., Gómez-Ambrosi, J. Rationale for the existence of additional adipostatic hormones.


Key Words: leptin • parabiosis • lipostatic factor • obesity • energy balance


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 
OVER THE PAST four decades, evidence for the existence of physiological systems aimed at body weight homeostasis has been provided. The concept that circulating signals generated in proportion to body fat stores influence appetite and energy expenditure in a coordinated manner to regulate body weight was first proposed by Kennedy (1) . According to his model, changes in energy balance sufficient to alter body fat stores are signaled via one or more circulating factors that act in the brain to elicit compensatory changes in order to match energy intake to energy expenditure. Two decades later, Coleman (2) in his classic parabiosis studies provided evidence that such circulating signals exist. In those experiments, two mice were surgically joined to permit vascular anastomosis. By joining the circulatory systems of severely obese mice of two different strains (ob/ob and db/db) to wild-type animals and to each other, he found that the obese gene (ob) mutation lacked the production of a circulating anorexic factor whereas the diabetes gene (db) mutation impaired the response to this factor.

The cloning in late 1994 of the ob gene (3) demonstrated that it encodes a 16 kDa protein, termed OB protein or leptin, synthesized mainly by fat cells and secreted into the bloodstream. Moreover, correction of leptin deficiency in ob/ob mice by exogenous administration caused a marked reduction in food intake and a normalization of the obesity syndrome (4 5 6) . Subsequent studies determined that the db mutation resides in the gene encoding the leptin receptor (7 , 8) . Therefore, leptin was thought to be the long-sought blood-borne factor working as a negative feedback signal critical to the normal control of food intake and body weight, which explained all the observations made in the different parabiosis studies.


   HYPOTHESIS
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 
The early parabiosis experiments with genetically obese mice indicated that a blood-borne satiety factor to which they were not sensitive was present in excess in db/db mice and absent in ob/ob animals. The discovery of leptin seemed to have provided the missing piece of the puzzle. However, from a closer look at the outcome of the parabiotic studies it becomes evident that leptin alone does not explain all the findings of the parabiotic experiments. Another (or more than one) yet unidentified factor(s) may be involved in energy balance regulation. Evidence for the existence of further leptin-like hormones comes mainly from observations made in different areas: 1) transplantation of isolated pancreatic islets; 2) adrenalectomy; 3) ovariectomy; 4) gavage overfeeding; 5) replication of the early parabiosis experiments with and without the currently available exogenous administration of leptin; 6) restoration of reproductive performance under certain experimental conditions; 7) the presence of torpor in food-restricted fatless transgenic mice; and 8) adaptation of food ingestion to environmental temperature.


   PARABIOSIS EXPERIMENTS
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 
Technical considerations
Parabiosis is the surgical union of two animals that leads to development of a common circulation. The technique usually includes celio-anastomosis as well as anastomosis of the skin from the shoulder to the pelvic girdle (9) . A longitudinal incision is made along opposed adjacent flanks of each rodent and the skin is loosened from connective tissue. The adjoining muscles on the lateral side of the peritoneum of the two animals are then divided and the abdominal muscles on the right side of one rodent are sutured to the abdominal muscles on the left side of the other animal so that peritoneal surfaces are connected. Thoracic muscles and peritoneal walls are joined by shallow silk sutures to prevent fluid accumulating in the dead space between the animals. The ventral edges of the incision are joined by suture. Femurs are exposed by separating surrounding muscles. Periosteum is scraped off the exposed surfaces, and the femurs are joined by suturing twice around the bones. Deep sutures are made between adjacent muscles to support the union and prevent animals from pulling themselves apart. Likewise, scapulas are exposed by removing the covering muscles, scraping off periosteum, suturing through the bones twice, and joining the surrounding muscles to stabilize the union. Finally, the dorsal edges of the skin incisions are joined. Subsequent histological examinations reveal the development of fibrous tissue and vascular, but not neural, connections between the two animals (10) .

Fifteen days after surgery, blood exchange in parabiotic pairs is measured by a bolus injection of Evans blue dye into the jugular vein of one of the rodents. Forty to 50 min later, a 100 µl blood sample is collected by tail bleeding from both members of the pair. Exchange is confirmed by blue coloration of serum collected from the noninjected animal. In rodents, the rate of blood exchange between partners is relatively slow, with ~1.0–2.8% of the blood volume of each animal exchanging per minute (11 , 12) . The ability of a factor to successfully pass between parabionts is not determined by size, as erythrocytes can exchange between parabiosed rats (10) . The slow rate of exchange determines which hormones produced in one animal can deliver bioactivity to the partner, and only those compounds with a relatively long half-life cross the union faster than they are cleared from the circulation. When one member of a parabiosed pair of rats receives an intravenous injection of dye, the dye concentration reaches equilibrium after ~ 2 h (11) . The extended period of time required for equilibration means there is a concentration gradient for many nutrients and hormones that have a short circulating half-life and are metabolized faster than they exchange between parabiotic partners (12) . Thus, parabiosis poses a functionally complete barrier to the exchange of short-lived circulating factors.

Hypothalamic lesions
Early studies with brain-lesioned rats showed that appropriately placed lesions in the hypothalamus cause hyperphagia and obesity in single animals (13) . Lesions made by the same technique produced essentially similar results in parabiotic rats (9) . Moreover, Hervey was the first to report that the production of obesity by lesioning the ventromedial hypothalamus (VMH) in one member of a parabiotic union led to hypophagia and weight loss in the unlesioned parabiont, which showed no interest in food despite progressive emaciation that frequently culminated in death (Fig. 1 ). At autopsy, unlesioned rats showed loss of all body fat stores and atrophy of the gastrointestinal tract and liver with no other apparent cause of death other than starvation (9) . Hervey concluded that a circulating satiety factor was produced by the lesioned parabiont as body fat accumulated. Whereas this rat was rendered insensitive to the factor by VMH destruction, the unlesioned parabiont became hypophagic in response to the high level of the satiety signal transmitted across the parabiotic union. As a further corroboration, Hervey produced VMH lesions in the lean parabionts to find that eating was quickly resumed, with body weight and body fat rebounding to values threefold those of unoperated single littermates (9) .



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Schematic representation of experimental results obtained after hypothalamic lesions in parabiotic normal rats.

Parameswaran et al. (14) created parabiotic rat pairs and placed stimulating electrodes into the lateral hypothalamus of one of the parabionts. Marked hyperphagia and obesity in the operated parabiont were produced by three daily stimulation sessions of the lateral hypothalamus. As the stimulated rat gained weight, the thin parabiont ate progressively less in accordance with Hervey’s findings. At the time of death, the stimulated animal showed a tremendous adipose tissue mass expansion, whereas the thin partner was essentially devoid of fat. Glucose, insulin, and glucagon concentrations of the thin parabionts were not increased, suggesting that none of these factors was responsible for the hypophagia of these rats (14) .

Genetic obesity
In 1950 the appearance of a recessive mutant associated with massive obesity was reported (15) . The genetic defect in the obese or ob/ob mouse is a single autosomal recessively inherited disease manifested early in life that is also associated with diabetes. Shortly after discovery of the ob/ob mouse, a second recessively inherited form of obesity, called diabetes or db/db mouse, was described (16) . That ob/ob and db/db mice are phenotypically identical when expressed on the same genetic background yet genetically different was initially interpreted as a genetic defect at two steps of the same metabolic pathway (17) . The search for the underlying biochemical and physiological mechanism of these animal models of early-onset obesity and diabetes syndromes was tackled by performing parabiosis experiments.

When parabiont pairs of db/db with normal (+/+) mice were produced, it was observed that the lean littermates had decreased food intake, rapidly lost weight, became hypoinsulinemic and hypoglycemic, and died of apparent inanition within 50 days after surgery (Fig. 2 ), whereas the diabetic partners that had been food-restricted before the union gained weight easily and became obese (18) . Similarly, when ob/ob mice were parabiosed with db/db mice, the ob/ob partner lost weight, experienced a dramatic adipose tissue mass reduction, exhibited hypoinsulinemia and hypoglycemia, and finally died of starvation whereas the db/db parabiont increased body weight (Fig. 2) . These findings pointed to the same kind of response in ob/ob mice and lean control littermates; i.e., the existence of normal satiety centers responsive to a circulating satiety factor (2 , 17) . Both partners survive in unions of ob/ob with normal mice, suggesting that the obese parabiont, unlike the db/db mice, does not produce the satiety factor necessary to turn off the normal partner’s eating drive (Fig. 3 ). However, ob/ob mice in such pairs exhibited decreased food intake and gained weight less rapidly than when parabiosed to other ob/ob mice (2 , 17) . Earlier, Hausberger (19) had reported that non-obese mice suppress the weight gain of ob/ob littermates in parabiosis. However, when the two animals were separated, the obese mouse rapidly regained weight. Hausberger concluded that obesity was not caused by the inherent qualities of adipose tissue itself but by the lack of a factor that could be transmitted by successful parabiosis. Partners of parabiotic unions between control +/+ mice lost some weight initially (Fig. 3) , but maintained normal plasma glucose and insulin concentrations despite a slight tendency toward hypoglycemia (2 , 17) . These experiments suggested that the ob/ob mouse is unable to produce a sufficient satiety factor to regulate its food consumption, whereas the db/db mouse produces the factor in excess but cannot respond to it because of a defective satiety center. Consistent with this explanation, parabiosis of either ob/ob or db/db mice with rodents of their same strain is not lethal to the different parabionts but does not prevent the obesity–diabetes syndrome (Fig. 4 ).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 2. Outcome of parabiotic unions of db/db mutants with ob/ob mice and normal lean littermates (+/+). Before parabiosis, obese and diabetic mice had been food-restricted for 6 wk to attain body weights similar to those of the (+/+) mice. Feeding ad libitum was allowed during the parabiotic period.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 3. Parabiosis of ob/ob mice with normal lean littermates and of (+/+) mice with animals of their same strain. Before parabiosis, obese mice had been food-restricted for 6 wk to attain body weights similar to those of the (+/+) mice. Feeding ad libitum was allowed during the parabiotic period.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 4. Homogeneous parabiotic pairs of diabetic or obese genotypes survive and maintain their phenotypic features. Before parabiosis, ob/ob and db/db mice had been food-restricted for 6 wk. Feeding ad libitum was allowed during the parabiotic period.

Forced overfeeding
Tube feeding experiments also support the concept of a circulating satiety factor. When excess caloric intake is provided to one animal by intragastric intubation, the combined spontaneous intake falls below the baseline level of food consumption of control pairs, demonstrating the development of hypophagia in both parabionts (11) . In addition, fat pad weights are significantly smaller in the non-tube-fed parabiont, an indication that caloric intake is below that needed to maintain body fat stores (Fig. 5 ). The mechanism of this weight loss appeared to be a 5–10% reduction in caloric intake by the lean parabionts (12) . Although this degree of anorexia is modest compared with that reported for the partners of VMH-lesioned rats, it is striking in view of the hyperphagia expected for the 60% reduction in body fat content induced in the lean parabionts (12) . When overfeeding is discontinued, the body composition of both partners returns to normal, thus showing that the changes observed are not due to nonspecific effects of parabiosis (20) . Therefore, overfeeding one animal leads to depression of food intake in the other via a humoral or ergostatic, i.e., an energy stabilizing, mechanism. Measurement of circulating concentrations of glucose, free fatty acids, ß-hydroxybutyrate, insulin, corticosterone, and growth hormone indicated that none of these factors can account for the loss of body fat (12) . In further studies of overfed rats, Harris et al. (21) elegantly demonstrated the existence of a serum factor that directly inhibited lipogenesis.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. Schematic representation of experimental results obtained after gavage overfeeding of parabiotic normal rats.

Because in gavage overfeeding food is delivered directly to the stomach, numerous gastrointestinal, hepatic, or pancreatic factors must be considered as potential candidates for the satiety factor. Taking into account the exchange kinetics of parabiosis experiments, it is unlikely that the satiety factor that passes from the obese to the lean animal is a short-acting gastrointestinal meal termination signal. Experimental confirmation of this reasoning was provided by training normal-weight rats in parabiosis to consume their total daily chow diet during a 2 h period (22) . When the rats were placed in partitioned cages and one parabiont was fed 2 h ahead of the other, food intake of the parabiont fed second was unaffected. Because circulating meal-related satiety signals in the rodent fed first should still have been elevated, it can be inferred that these signals do not pass to the other animal. Therefore, the satiety induced in the partners of experimentally obese parabiotic rats must be related to the increased body fat content of the obese animals rather than to signaling elicited by the filling of the gastrointestinal system. There are various likely sites for the origin of an ergostatic factor. The most obvious seems to be the expanding fat depot; it is conceivable that as adipose tissue mass enlarges, a factor that acts as a sensing hormone or ‘lipostat’ in a negative feedback control from adipose tissue to hypothalamic receptors informs the brain about the abundance of body fat, thereby allowing feeding behavior, metabolism, and endocrine physiology to be coupled to the nutritional state of the organism.


   UNEXPLAINED FINDINGS
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 
Although leptin’s physiological effects fit the characteristics described for the proposed circulating satiety factor in the classic parabiosis studies, there are some other experimental findings that cannot be adequately explained. These observations come from findings made in quite diverse experimental settings in which the direct effect of leptin is eliminated or excluded.

Pancreatic islet transplants
Strautz (23) has shown that transplantation of isolated pancreatic islets from normal to obese ob/ob mice stabilizes the rate of weight gain and reduces both hyperglycemia and hyperinsulinemia. This study implied that the missing satiety factor may be of pancreatic origin. Similar islet transplant studies undertaken in another genetic model of obesity, the polygenic New Zealand obese (NZO) mouse, further support the existence of an islet factor. These mice become obese early in life, have increased adiposity, and are both hyperglycemic and hyperinsulinemic (24) . It has been shown that when NZO mice are implanted with islets isolated from normal albino mice, the weight gain of the obese rodents is reduced and both plasma glucose and insulin concentrations are significantly lowered (25) . Furthermore, glycemia and insulinemia could be decreased to normal concentrations by intraperitoneal (i.p.) implantation of pancreatic islets from albino mice that had undergone a selective destruction of ß cells by streptozotocin (26) . It would seem, therefore, that the genetic lesion responsible for the NZO syndrome lies within the islets of Langerhans and not within the ß cell. Hyperleptinemia has been reported in NZO mice although they do not appear to carry mutations in either leptin or leptin receptor genes (5 , 27) . These rodents do not decrease food intake in response to peripheral leptin administration, although intracerebroventricular infusion of leptin causes a decrease in food consumption whereas energy expenditure is unchanged, thus leading to a negative energy balance (5) .

Adrenalectomy
The obesity of both leptin-deficient and leptin receptor-deficient rodents does not progress after adrenalectomy, showing that removal of the adrenal cortex is sufficient to impair the development of these genetic models of obesity (28) . In the absence of glucocorticoids of adrenal origin, food intake normalizes, muscle mass increases, hyperglycemia abates, and insulin resistance disappears. The reduced fat deposition that occurs after adrenalectomy has been shown to be due to a large decrease in the efficiency of energy utilization associated with a restoration of brown fat activity (29) . The reversal of the obesity–diabetes syndrome after adrenalectomy is obviously attained without the involvement of leptin and provides evidence for an important role of glucocorticoids in the development of the pathophysiological characteristics of obesity. It is striking that consumption of either a high-glucose or a high-fat diet prevents the aforementioned effects of food intake reduction and body weight gain associated with adrenalectomy, indicating that factors other than adrenal secretions, which are influenced by diet composition (particularly with highly palatable diets), mediate the development of obesity (30 , 31) .

Adrenalectomy, however, does not restore infertility, indicating that not all metabolic and endocrine alterations associated with genetic models of obesity can be explained by a single factor. Furthermore, the role of glucocorticoids of adrenal origin in the phenotypic expression differs depending on the experimental model of obesity. Whereas adrenalectomy reduces the hyperphagia characteristic of ob/ob mice, in obesity mediated by gold thioglucose treatment adrenalectomized animals develop severe anorexia, exhibit progressive weight loss, and die within several weeks of the surgical intervention (32) .

Ovariectomy
The role of estrogens in the development and topography of adipose tissue has been documented for decades (33) . Castration of female obese rodents has a profound effect on body fat, increasing the amount and changing its distribution as well as increasing food intake and decreasing the activity of the sympathetic nervous system. Estrogenic replacement by either peripheral or direct hypothalamic application reverses the effects after ovariectomy. Additional evidence for the critical role of estrogen signaling in white adipose tissue expansion comes from knockout experiments where mice lacking estrogen receptor {alpha} exhibit increased fat pad weight together with augmented adipocyte size and number (34) . Thus, estrogen seems to be an integral part of the feeding and reproductive systems. It is noteworthy that adrenalectomy prevents the obesity after ovariectomy just as it does in leptin deficiency and VMH-lesioned induced obesity (35) .

Gavage overfeeding
The time lag observed in the manifestation of some of the different biological effects that occur in tube feeding parabiotic experiments deserves some consideration. On the one hand, the changes in body composition of partners of obese rats are not apparent until overfeeding has continued for at least 23 days (12) , which implies that the lipid-depleting factor is produced in response to a substantial increase in body fat of the tube-fed rat. On the other hand, the effects on food appetite take place in an acute way. If a lipostatic factor produced by the forced-fed animal is responsible for the anorexic effect of the ad libitum-fed parabiont, a gradual decline in food intake in the non-tube-fed parabiosed animal would be expected as fat pads enlarge. However, food intake drops within the first 2 days (when no evident changes in body composition have taken place) and shows no further decline as fat depots are filled (11) . Although this divergence in the time-related effect on food consumption and body composition may appear paradoxical, it can be explained by assigning leptin a more dynamic role in whole-body physiology with a simultaneous participation in both short- and long-term events. Based on a somewhat static view of the hormone, leptin’s function was seen initially only as informing the brain about the abundance of body fat, acting as a sensing hormone in a negative feedback control from adipose tissue to the hypothalamus (3 4 5 6) . However, as would be predicted of a factor playing a key role in energy balance, expression of the ob gene is subject to quick regulation. Without a parallel decrease in body fat stores, short-term fasting induces a marked fall in ob mRNA, and consequently in circulating leptin concentrations, that is rapidly reversed upon refeeding (36) . Thus, some metabolic and hormonal actions of leptin precede its effects on appetite or body weight, operating independently of changes in food intake and fat size stores (37) .

Replication of early parabiosis studies
Coleman’s findings with ob/ob and lean parabiosed mice showing that the obese parabiont ate less, gained less weight, and had a marked insulin reduction (2) were confirmed in a recent study by Harris (38) . However, the reduction in carcass weight of ob/ob partners of lean mice vs. their controls was not statistically significant and the reduction in carcass fat from 56 to 48% of carcass weight was smaller than anticipated (38) . In principle, these observations are all consistent with leptin produced by the lean parabiont being carried in the circulation to the obese partner. In fact, measurement of leptin confirmed the presence of this hormone in the blood of the ob/ob mice parabiosed to lean littermates (38) . In addition, the recent study found that lean partners lost more fat than the obese animals (37% vs. 14%, respectively) in the absence of significant changes in food intake (38) . Despite the 37% reduction in body fat, it is surprising that neither leptin expression nor circulating leptin concentrations were decreased in lean mice parabiosed to ob/ob mutants. These findings suggest that in lean ob/ob pairs, the ob/ob mice respond to leptin delivered by the lean parabiont, whereas the lean partner responds to a circulating signal, presumably originating in the ob/ob parabiont, that maintains leptin expression at inappropriate levels for the degree of adiposity of the lean animal (38) . Increased secretion of leptin cannot be attributed to the ob/ob partner acting as a sink that absorbs all of the OB protein and thus stimulates protein production, because circulating leptin concentrations in lean mice of ob/ob parabionts were the same as those in lean controls.

Many parabiotic pairs were reported to be lost to hypothermia in the ob/ob partners (38) . Body temperature lability of these rodents in parabiosis shows impaired thermoregulation. Although the amount of leptin exchanging between lean and ob/ob partners was adequate to normalize serum insulin concentrations and decrease food intake and weight gain, it was not enough to raise body temperature (38) . These observations together with the thermogenic effect elicited in ob/ob mice by administration of high leptin concentrations (6) indicate that large amounts of the OB protein are required to induce hyperthermia.

Parabiosis of ob/ob to db/db mice confirmed the previous results of Coleman (2) in which ob/ob partners experienced a rapid weight loss, exhibited a reduced food intake, and became hypoglycemic (39) . In the more recent study by Harris (39) , special attention was directed to monitoring changes in body composition, which had not been addressed previously. The weight of ob/ob mice parabiosed to db/db rodents was halved and body fat was reduced by 60%. The loss of fat was associated with a substantial reduction in food intake. Despite this extremely high rate of fat catabolism, lean tissue of ob/ob mice was maintained, demonstrating a tissue-specific energy mobilization. Surprisingly, parabiosis of the db/db mouse to the ob/ob partner caused in the former a small, but significant, reduction in carcass fat and a significant 30% increase in carcass protein (39) . Altogether, these findings suggest that leptin reaching the ob/ob mice through the parabiotic union leads to the release of another circulating factor that promotes protein conservation in the leptin-deficient mice. When this unknown circulating growth factor is carried back to the db/db partner, it seems to induce protein deposition in the leptin receptor-deficient rodent.

The elevation of rectal temperature in ob/ob, but not db/+, partners of db/db mice confirmed previous observations that leptin corrects hypothermia but does not induce hyperthermia in an animal that maintains a normal body temperature (6 , 40) .

When exogenous treatment with leptin became feasible, replication of the classic parabiosis experiments was carried out to verify that leptin was the long-sought circulating factor (41) . Twice-daily i.p. injections of recombinant murine leptin (50 µg/day) resulted in extremely high serum concentrations of leptin at intermittent intervals (200–700 ng/ml). The first conclusion obtained was that the circulating half-life of recombinant murine leptin is ~36 min (41) . The rate of protein clearance determined would allow leptin to exchange between parabiosed mice, but would not exchange fast enough to reach equilibrium if there was a large difference in concentrations of leptin in the two members of the pair. The failure of leptin to reach equilibrium was confirmed by measurement of the circulating protein, which showed that 2 h after injection, the OB protein was present at higher concentrations in the treated member of the parabiosed pair than in its partner (41) . It was further observed that leptin treatment of one member of a parabiosed pair of ob/ob mice reduced serum insulin, food intake, and body fat in both partners (Fig. 6 ). The injected parabiont lost more fat than its partner, whereas body temperature was increased only in the injected mouse. The normalization of serum insulin concentrations was apparent in all mice, independent of the change in body fat content, indicating that improved insulin sensitivity is a primary effect of leptin. No effect on serum corticosterone concentrations or adrenal weight was observed. Whereas leptin administration to single ob/ob mice has been shown to increase the weights of reproductive organs (42) , injection of recombinant leptin to ob/ob parabiosed mice had no effect (41) .



View larger version (11K):
[in this window]
[in a new window]
 
Figure 6. Effects of replication of the classic parabiotic studies with twice-daily i.p. injections of leptin (25 µg) to one of the partners.

The differences observed in physiological effects between the treated parabiont and its partner despite the high circulating concentrations attained illustrate a gradation in the response to leptin. The decrease in serum insulin concentrations is the most sensitive response and is corrected in both the injected mouse and its partner. Changes in body fat content are greater in the injected animal than in the partner. The increase in body temperature is the least sensitive of the effects measured, being evident only in the leptin-treated parabiont (41) . However, the possibility that these graded effects of leptin on different biological functions are linked to the intermittent, twice-daily injections of the protein as opposed to a physiological, continuous slow release also has to be considered (43) .

In Coleman’s classic experiments, both +/+ and ob/ob mice died of starvation when parabiosed to db/db mice (2 , 17 , 18) . When the nature of the genetic defects in these mice was established and exogenous treatment with leptin became available, it was realized that leptin alone is not involved in the effects of parabiosis, since leptin-treated wild-type or ob/ob mice do not die from starvation (44) . Therefore, the hyperleptinemia in db/db mice may be accompanied by a high concentration of another anorectic factor that is more powerful than leptin itself or acts synergistically with leptin, potentiating its effects in mice. The integrity of the leptin signaling system appears to be necessary for the anorectic effect of the putative factor since otherwise food intake would have to be limited in db/db mice themselves. Potential explanations lie in the possibility that leptin and the other factor share the same receptor, that db/db mutants are also deficient in the receptor of this factor, or that leptin plays a permissive role in the development of the anorectic effect of the putative factor.

Adipose-derived satiety activity
After the demonstration that recombinant leptin behaves as a prototype adipose satiety factor (4 5 6) , only Weigle’s group (45 , 46) has attempted to characterize the satiety activity of native adipose tissue. Initially, it was reported that medium conditioned by adipose tissue from db/db mice contains immunoreactive leptin and can suppress food intake for a 24-h period after i.p. injection in ob/ob mice (45) . The subsequent study focused on a more complete characterization of adipose-derived satiety activity (46) . It was concluded that adipose-derived satiety activity is not fully explained by leptin. Adipocytes may secrete other factors that augment leptin action or secrete leptin in a form that has greater biological activity. In addition to leptin and insulin, other molecules secreted by adipocytes may be involved in the feedback loop that communicates the status of the body’s energy reserves to the brain. A leptin cofactor might be produced constitutively by adipose tissue and secreted as a complex with leptin, or production of the putative leptin cofactor might be regulated by a variety of metabolic or hormonal molecules (46) . Variability or relative deficiency of the putative leptin cofactor could account for a variable or diminished ability of leptin to elicit satiety and curtail weight gain. In view of the striking redundancy of hypothalamic pathways and neurotransmitter systems controlling feeding, the existence of presently uncharacterized molecules involved in the feedback loop between adipose tissue and the central nervous system might be predicted.

Restoration of reproductive performance
Leptin quickly proved to play an important role in reproductive physiology (47 , 48) . Whereas sterility was a well-recognized feature in ob/ob mice, exogenous administration of leptin to these mice was shown to increase the weight of ovaries and uterus, thus showing a trophic action of leptin on gonadal function. Long-term injections of leptin have been reported to correct the sterility of female (49) and male (50) adult ob/ob mice, which does not appear to be a consequence of weight change per se since weight loss in control ob/ob animals due to food restriction did not ameliorate infertility (49 , 50) . In addition, leptin has been shown to accelerate the onset of puberty in normal mice. Normal prepubertal female mice injected with leptin experienced an earlier maturation of the reproductive tract accompanied by a precocious onset of classic pubertal signs like vaginal opening, estrus, and cycling (51) . In accordance with these findings, leptin is increased in both boys and girls before the appearance of other reproductive hormones related to puberty (36 , 47 , 48) . Therefore, leptin signals the adequacy of energy stores and seems to be needed for the initiation of puberty and establishment of secondary sexual characteristics by interacting with different target organs in the hypothalamic-pituitary-gonadal axis.

Surprisingly, a genetically leptin-deficient women who entered puberty in her late 20s (52) and a female with congenital lipodystrophy who had extremely low leptin concentrations but underwent a normal reproductive progression (53) both suggest the existence of alternative mechanisms regulating reproductive performance. Thus, in the absence of a crucial factor such as leptin, other factors may be stimulated to rescue the reproductive system. This plausible explanation is actually supported by studies showing that leptin-deficient ob/ob males bred on a mixed C57Bl/6J and BALB/cJ genetic background (54) and ob/ob males and females backcrossed for 10 generations to the BALB/cJ background (48) are fertile. Furthermore, genes that allow reproduction in severely undernourished male, but not female, mice have been shown to be present in wild house mice and presumably persist in some laboratory mouse strains (55 , 56) . Altogether, these observations suggest that leptin is not essential for reproduction when other, as yet unidentified factors are present.

Presence of torpor in food-restricted ob/ob and fatless transgenic mice
Torpor is a state of physical inactivity, reduced core body temperature, and decreased metabolic expenditure. It has been documented that mice can enter torpor when there is a quiet environment, food scarcity, and a low ambient temperature (57) . During deep torpor, mice maintain a core body temperature down to a minimum of 16–19°C. Owing to sufficient food supply and adequate room temperatures, deep torpor is rarely seen in laboratory mice. The ob/ob mouse is an exception, entering torpor even when well fed and housed at room temperature (58) . To study the role of adipose tissue and leptin in the regulation of entry into torpor, researchers have used two leptin-deficient animal models: massively obese ob/ob mice and virtually fat-depleted A-ZIP/F-1 transgenic mice (59) . The A-ZIP/F-1 phenotype has virtually no white fat and a reduced amount of brown adipose tissue (BAT) (60) . Thus, even though both are hypoleptinemic, ob/ob and A-ZIP/F-1 mice provide an important contrast: the former has massive triglyceride stores and the latter exhibits very low energy reserves. A-ZIP/F-1 mice down-regulate their metabolic rate early in fasting and then go into deep torpor to conserve energy (59) . In fasted ob/ob mice, leptin replacement prevented deep torpor and the modest hypothermic state. In contrast, in fasted A-ZIP/F-1 mice, leptin treatment did not prevent torpor. These findings suggest that torpor in rodents is induced by both leptin-dependent and -independent mechanisms (59) . In the setting of large energy stores leptin administration (e.g., in leptin-treated ob/ob mice), the OB protein plays a key role in torpor induction. However, the occurrence of profound torpor in food-restricted mice with no white fat tissue that is not preventable by leptin administration indicates another factor may be important in the adaptation of mice to starvation. This role has been ruled out for thyroid hormones and ß3 agonists, important regulators of basal metabolic rate (59) .

Adaptation of food ingestion to environmental temperature
Mice maintain thermal balance over a wide range of ambient temperatures, from thermoneutrality down to mild cold (61) . Thus, mice can adjust their energy expenditure over a fivefold range in order to maintain thermal balance. At the same time, mice are also able to adjust their food intake over this same fivefold range so as to maintain their fat stores while living at a wide range of ambient temperatures (61) . The nature of the signal that informs a mouse that it should match its energy intake to its energy expenditure is unknown, as is the nature of the neuropeptidergic pathways that control the thermal balance feeding system. Changes in leptin concentrations are not involved, since mutants that lack either leptin or leptin receptors can still adjust their food intake in accordance with acclimation temperature (62) . The principal site of thermogenesis in mice acclimated to different ambient temperatures below thermoneutrality is BAT. Some insight into the control system underlying thermal balance feeding has come from studies with BAT-ablated mice (61 , 63 64 65) . These mice carry a transgene containing diphtheria toxin A chain (DTA) linked to the uncoupling protein-1 promoter (UCP-DTA mice) (66) . In these mice, the development of obesity was predicted on the basis of the expected deficit in energy expenditure for the observed level of thermogenesis. However, UCP-DTA mice also become hyperphagic, a consequence of BAT ablation that was not anticipated by any known function of BAT. Moreover, it has been shown that lack of UCP1-mediated thermogenesis does not in itself induce obesity or hyperphagia (67) . Thus, other underlying mechanisms for the hyperphagia of UCP-DTA mice must be sought. It has been proposed that UCP1-expressing brown adipocytes secrete a satiety factor in inverse relation to environmental temperature and sympathetic stimulation as well as being able to operate independently of changes in leptin concentrations (61 , 65) . The generation of this signal would be maximal at thermoneutrality, progressively suppressed by norepinephrine as acclimation temperature decreases and sympathetic nervous system activity increases, and minimal in a cold environment in which sympathetic activity reaches its maximum level. UCP-DTA mice are predicted to secrete this factor normally at thermoneutrality but presumably lose the ability to secrete it at usual animal house temperatures (22–24°C). Thus, at ambient temperature, UCP1-expressing brown adipocytes die; UCP-DTA mice are unable to produce the putative satiety factor and consequently become hyperphagic (61 , 65) . The main function of this unknown factor would be (mediated by a decrease in its concentration) to promote an increase in food intake to match the increasing energy expenditure as environmental temperature decreases.


   FUTURE PERSPECTIVES
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 
Unraveling the diverse hormonal and neuroendocrine systems that regulate energy balance and body fat has been a long-standing challenge in biology, with obesity an increasingly important public health focus. A major development in the understanding of energy balance regulation has come with identification of the protein product of the ob gene. Leptin was discovered through positional cloning late in 1994 after an 8-year search by Friedman’s team at Rockefeller University (3) . Since then, remarkable progress has been made in the application of genetics to understand the control of body weight (68) .

The application of transgenic technologies in life science research has become widespread. Within the field of bioenergetics and metabolism, their application had been expected to provide definitive evidence for many longstanding metabolic hypotheses and theories. The expectation is generally founded on one of the prevailing benefits of transgenic technologies—the ability to decipher the importance of a specific protein under in vivo conditions. During the elaboration of this hypothesis, identification of a series of new molecules implicated in obesity and adipose tissue development has been published. The gene Lpin1 has been shown to encode a novel nuclear protein, which has been named lipin (69) . The identification of lipin has revealed a new factor required for normal adipose tissue development and metabolism. Elucidation of the molecular function of lipin will likely lead to new insights into these processes. This novel family of nuclear proteins contains at least three members in mammalian species as well as homologs in distantly related organisms from human to yeast. The human ortholog LPIN1 is a potential candidate gene for lipodystrophy, a heterogeneous group of disorders with unknown genetic determinants (except for LMNA, which is responsible for Dunnigan-type familial partial lipodystrophy).

A variety of adipocyte-derived molecules have been proposed as potential mediators of the resistance to insulin associated with obesity. Recently, the discovery of a novel hormone, which the researchers named resistin (for resistance to insulin), was reported (70) . Resistin is specifically expressed and secreted by adipocytes, apparently in proportion to fat pad size. It impairs glucose tolerance and insulin action, thus linking obesity to diabetes. Resistin seems to be part of an emerging new family of secreted proteins with a tissue-specific pattern of expression and probably common signaling characteristics. Two other members of the family resistin-like molecule {alpha} and ß (RELM{alpha} and ß) have been cloned (71) . RELM{alpha} is expressed in white adipose tissue (apparently in the stromal vascular constituents rather than in adipocytes), mammary gland, heart, lung, and tongue; it has unknown biological functions. RELMß is expressed and secreted in the gastrointestinal tract only, especially in the colon, and at lower levels in the cecum and ileum. The expression of RELMß is higher in proliferative epithelial cells and is markedly up-regulated in tumors, suggesting a role for this protein in proliferation.

We were still trying to digest all the information derived from these findings when the outcome of knocking out the glucose transporter gene GLUT4 was published this year (72) . These knockout mice have normal growth and adipose tissue mass despite markedly impaired insulin-stimulated glucose uptake in adipocytes. Although GLUT4 expression is preserved in muscle, these rodents develop insulin resistance in muscle and liver, manifested by decreased biological responses and impaired activation of phosphoinositide-3-OH kinase. Therefore, adipose-selective depletion of GLUT4 in mice leads to impaired glucose tolerance and insulin resistance with preserved adipose mass. Insulin resistance occurs secondarily in muscle and liver, as evidenced by defective proximal signaling and reduced physiological responses. Moreover, the insulin resistance cannot be accounted by changes in circulating free fatty acids, triglycerides, or leptin or by changes in tumor necrosis factor {alpha} expression in adipose tissue. Thus, selective down-regulation of GLUT4 and glucose transport in adipose tissue can cause insulin resistance and thereby increase the risk of developing diabetes.

The pace of advance is likely to accelerate as functional genomics and the human genome project expand and mature. The reasoning underlying the hypothesis of the existence of further leptin-like products relies on the fact that nature has carved a web of factors essential to ensure its own survival. Basic physiological insight like the one provided by this hypothesis is sorely needed in order to enhance the ‘targeted’ identification of further satiety factors, fat controllers, or lipostatic hormones. Future studies aimed at identifying the aforementioned yet unknown factors may cast new light on the causes underlying human obesity and broaden our knowledge of the pathophysiology of this multifactorial disease.


   ACKNOWLEDGMENTS
 
The general support of the departmental chair for Dr. Javier Salvador is gratefully acknowledged.

Received for publication March 28, 2001. Revision received May 24, 2001.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
HYPOTHESIS
PARABIOSIS EXPERIMENTS
UNEXPLAINED FINDINGS
FUTURE PERSPECTIVES
REFERENCES
 

  1. Kennedy, G. C. (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. London Ser. B 140,578-592[Medline]
  2. Coleman, D. L. (1973) Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9,294-298[Medline]
  3. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J. M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature (London) 372,425-432[Medline]
  4. Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., Burn, P. (1995) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269,546-549[Abstract/Free Full Text]
  5. Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., Friedman, J. M. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269,543-546[Abstract/Free Full Text]
  6. Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., Collins, F. (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269,540-543[Abstract/Free Full Text]
  7. Chua, S. C., Jr, Chung, W. K., Wu-Peng, X. S., Zhang, Y., Liu, S.-M., Tartaglia, L., Leibel, R. L. (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (Leptin) receptor. Science 271,994-996[Abstract]
  8. Lee, G.-H., Proenca, R., Monte, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., Friedman, J. M. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature (London) 379,632-635[Medline]
  9. Hervey, G. R. (1959) The effects of lesions of the hypothalamus in parabiotic rats. J. Physiol. (London) 145,336-352
  10. Huff, R. L., Trautman, R., Van Dyke, D. C. (1950) Nature (London) of exchange in parabiotic rats. Am. J. Physiol. 161,56-74
  11. Nishizawa, Y., Bray, G. A. (1980) Evidence for a circulating regostatic factor: studies on parabiotic rats. Am. J. Physiol. 239,R344-R351
  12. Harris, R. B. S., Martin, R. J. (1984) Specific depletion of body fat in parabiotic partners of tube-fed obese rats. Am. J. Physiol. 247,R380-R386
  13. Harris, R. B. S. (1990) Role of set-point theory in regulation of body weight. FASEB J 4,3310-3318[Abstract]
  14. Parameswaran, S. V., Steffens, A. B., Hervey, G. R., de Ruiter, L. (1977) Involvement of a humoral factor in regulation of body weight in parabiotic rats. Am. J. Physiol. 232,R150-R157
  15. Ingalls, A. M., Dickie, M. M., Snell, G. D. (1950) Obese, a new mutation in the mouse. J. Hered. 41,317-318[Free Full Text]
  16. Hummel, K. P., Dickie, M. M., Coleman, D. L. (1966) Diabetes, a new mutation in the mouse. Science 153,1127-1128[Abstract/Free Full Text]
  17. Coleman, D. L. (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14,141-148[Medline]
  18. Coleman, D. L., Hummel, K. P. (1969) Effects of parabiosis of normal with genetically diabetic mice. Am. J. Physiol. 217,1298-1304
  19. Hausberger, F. X. (1959) Parabiosis and transplantation experiments in hereditarily obese mice. Anat. Rec. 130,313
  20. Harris, R. B. S., Martin, R. J. (1990) Site of action of putative lipostatic factor: food intake and peripheral pentose shunt activity. Am. J. Physiol. 259,R45-R52[Abstract/Free Full Text]
  21. Harris, R. B. S., Bruch, R. C., Martin, R. J. (1989) In vitro evidence for an inhibitor of lipogenesis in serum from overfed obese rats. Am. J. Physiol. 257,R326-R336[Abstract/Free Full Text]
  22. Schmidt, P., Andik, I. (1969) Regulation of food intake in parabiotic rats. Acta Physiol. Acad. Sci. Hungary 36,293-298
  23. Strautz, R. L. (1970) Studies of hereditary-obese mice (ob/ob) after implantation of pancreatic islets in Millipore filter capsules. Diabetologia 6,306-312[Medline]
  24. Robinson, S. W., Dinulescu, D. M., Cone, R. D. (2000) Genetic models of obesity and energy balance in the mouse. Annu. Rev. Genet. 34,687-745[Medline]
  25. Gates, R. J., Hunt, M. I., Smith, R., Lazarus, N. R. (1972) Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand Obese after implantation of islets of Langerhans. Lancet Ib,561-570
  26. Gates, R. J., Hunt, M. I., Lazarus, N. R. (1974) Further studies on the amelioration of the characteristics of New Zealand obese (NZO) mice following transplantation of islets of Langerhans. Diabetologia 10,401-406[Medline]
  27. Igel, M., Becker, W., Herberg, L., Joost, H. G. (1997) Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Endocrinology 138,4234-4239[Abstract/Free Full Text]
  28. Bray, G. A., York, D. A. (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59,719-809[Free Full Text]
  29. Marchington, D., Rothwell, N. J., Stock, M. J., York, D. A. (1983) Energy balance, diet-induced thermogenesis and brown adipose tissue in lean and obese (fa/fa) Zucker rats after adrenalectomy. J. Nutr. 113,1395-1402
  30. Smith, C. K., Romsos, D. R. (1985) Effects of adrenalectomy on energy balance of obese mice are diet dependent. Am. J. Physiol. 249,R13-R22
  31. Kang, J.-S., Pilkington, J. D., Ferguson, D., Kim, H.-K., Romsos, D. R. (1992) Dietary glucose and fat attenuate effects of adrenalectomy on energy balance in ob/ob mice. J. Nutr. 122,895-905
  32. Debons, A. F., Das, K. C., Fuhr, B., Siclari, E. (1983) Anorexia after adrenalectomy in gold thioglucose-treated obese mice. Endocrinology 112,1847-1891[Abstract]
  33. Ailhaud, G., Hauner, H. (1998) Development of white adipose tissue. Bray, G. A. Bouchard, C. James, W. P. T. eds. Handbook of Obesity 1st Ed ,359-378 Marcel Dekker New York.
  34. Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., Cooke, P. S. (2000) Increased adipose tissue in male and female estrogen receptor-{alpha} knockout mice. Proc. Natl. Acad. Sci. USA 97,12729-12734[Abstract/Free Full Text]
  35. Mook, D. G., Kenney, N. J., Robert, S., Nussbaum, A. I., Rodier, W. I., III (1972) Ovarian-adrenal interactions in regulation of body weight by female rats. J. Comp. Physiol. Psychol. 81,198-211[Medline]
  36. Frühbeck, G., Jebb, S. A., Prentice, A. M. (1998) Leptin: physiology and pathophysiology. Clin. Physiol. 18,399-419[Medline]
  37. Frühbeck, G., Aguado, M., Gómez-Ambrosi, J., Martínez, J. A. (1998) Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem. Biophys. Res. Commun. 250,99-102[Medline]
  38. Harris, R. B. S. (1997) Loss of body fat in lean parabiotic partners of ob/ob mice. Am. J. Physiol. 272,R1809-R1815[Abstract/Free Full Text]
  39. Harris, R. B. S. (1999) Parabiosis between db/db and ob/ob or db/+ mice. Endocrinology 140,138-145[Abstract/Free Full Text]
  40. Harris, R. B. S., Zhou, J., Redmann, S. R., Smagin, G. S., Smith, S. R., Rodgers, E., Zachwieja, J. J. (1998) A leptin dose response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 139,8-19[Abstract/Free Full Text]
  41. Harris, R. B. S., Zhou, J., Weigle, D. S., Kuijper, J. L. (1997) Recombinant leptin exchanges between parabiosed mice but does not reach equilibrium. Am. J. Physiol. 272,R1800-R1808[Abstract/Free Full Text]
  42. Frühbeck, G. (2001) A heliocentric view of leptin. Proc. Nut. Soc. In press
  43. Frühbeck, G., Diez-Caballero, A., Salvador, J., Alvarez-Cienfuegos, J. (2000) Chronobiology of recombinant leptin therapy. J. Am. Med. Assoc. 283,1567[Free Full Text]
  44. Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., Friedman, J. M. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 94,8878-8883[Abstract/Free Full Text]
  45. Weigle, D. S., Bukowski, T. R., Foster, D. C., Holderman, S., Kramer, J. M., Lasser, G., Lofton-Day, C. E., Prunkard, D. E., Raymond, C., Kuijper, J. L. (1995) Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96,2065-2070
  46. Weigle, D. S., Hutson, A. M., Kramer, J. M., Fallon, M. G. M., Lehner, J. M., Lok, S., Kuijper, J. L. (1998) Leptin does not fully account for the satiety activity of adipose tissue-conditioned medium. Am. J. Physiol. 275,R975-R985
  47. Holness, M. J., Munns, M. J., Sugden, M. C. (1999) Current concepts concerning the role of leptin in reproductive function. Mol. Cell. Endocrinol. 157,11-20[Medline]
  48. Chehab, F. F. (2000) Leptin as a regulator of adipose mass and reproduction. Trends Pharmacol. Sci. 21,309-314[Medline]
  49. Chehab, F. F., Lim, M. E., Lu, R. H. (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12,318-320[Medline]
  50. Mounzih, K., Lu, R., Chehab, F. F. (1997) Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 138,1190-1193[Abstract/Free Full Text]
  51. Chehab, F. F., Mounzih, K., Lu, R., Lim, M. E. (1997) Early onset of reproductive function in normal female mice treated with leptin. Science 275,88-90[Abstract/Free Full Text]
  52. Ozata, M., Ozdemir, I. C., Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84,3686-3695[Abstract/Free Full Text]
  53. Andreelli, F., Hanaire-Broutin, H., Laville, M., Tauber, J. P., Riou, J. P., Thivolet, C. (2000) Normal reproductive function in leptin-deficient patients with lipoatrophic diabetes. J. Clin. Endocrinol. Metab. 85,715-719[Abstract/Free Full Text]
  54. Ewart-Toland, A., Mounzih, K., Qiu, J., Chehab, F. F. (1999) Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140,732-738[Abstract/Free Full Text]
  55. Hamilton, G. D., Bronson, F. H. (1985) Food restriction and reproductive development in wild house mice. Biol. Reprod. 32,773-778[Abstract]
  56. Hamilton, G. D., Bronson, F. H. (1986) Food restriction and reproductive development: male and female mice and male rats. Am. J. Physiol. 250,R370-R376
  57. Kortner, G., Geiser, F. (2000) The temporal organization of daily torpor and hibernation: circadian and circannual rhythms. Chronobiol. Int. 17,103-128[Medline]
  58. Webb, G. P., Jagot, S. A., Jakobson, M. E. (1982) Fasting-induced torpor in Mus musculus and its implications in the use of murine models for human obesity studies. Comp. Biochem. Physiol. A 72,211-219[Medline]
  59. Gavrilova, O., Leon, L. R., Marcus-Samuels, B., Mason, M. M., Castle, A. L., Refetoff, S., Vinson, C., Reitman, M. L. () Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 96,14623-14628
  60. Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., Reitman, M. L., Vinson, C. (1998) Life without white fat: a transgenic mouse. Genes Dev 12,3168-3181[Abstract/Free Full Text]
  61. Himms-Hagen, J. (1999) Brown adipose tissue (BAT): role in energy expenditure and intake. Guy-Grand, B. Ailhaud, G. eds. Progress in Obesity Research: 8 ,27-31 John Libbey & Company Ltd. London, UK.
  62. Coleman, D. L. (1982) Thermogenesis in diabetes-obesity syndromes in mutant mice. Diabetologia 22,205-211[Medline]
  63. Hamann, A., Büsing, B., Kausch, C., Ertl, J., Preibisch, G., Matthaei, S. (1997) Chronic leptin treatment does not prevent the development of obesity in transgenic mice with brown fat deficiency. Diabetologia 40,810-815[Medline]
  64. Melnyk, A., Harper, M.-E., Himms-Hagen, J. (1997) Raising at thermoneutrality prevents obesity and hyperphagia in BAT-ablated transgenic mice. Am. J. Physiol. 272,R1088-R1093[Abstract/Free Full Text]
  65. Melnyk, A., Himms-Hagen, J. (1998) Temperature-dependent feeding: lack of role for leptin and defect in brown adipose tissue-ablated obese mice. Am. J. Physiol. 274,R1131-R1135[Abstract/Free Full Text]
  66. Lowell, B. B., Susulic, V. S., Hamann, A., Lawitts, J. A., Himms-Hagen, J., Boyer, B. B., Kozak, L. P., Flier, J. S. (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature (London) 366,740-742[Medline]
  67. Enerbäck, S., Jacobsson, A., Simpson, E. M., Guerra, C., Yamashita, H., Harper, M.-E., Kozak, L. P. (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature (London) 387,90-94[Medline]
  68. Barsh, G. S., Farooqi, I. S., O’Rahilly, S. (2000) Genetics of body-weight regulation. Nature (London) 404,644-651[Medline]
  69. Péterfy, M., Phan, J., Xu, P., Reue, K. (2001) Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27,121-124[Medline]
  70. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., Lazar, M. A. (2001) The hormone resistin links obesity to diabetes. Nature (London) 409,307-312[Medline]
  71. Steppan, C. M., Brown, E. J., Wright, Bhat, S.C. M., Banerjee, R. R., Dai, C. Y., Enders, G. H., Silberg, D. G., Wen, X., Wu, G. D., Lazar, M. A. (2001) A family of resistin-like molecules. Proc. Natl. Acad. Sci. USA 2001 98,502-506[Abstract/Free Full Text]
  72. Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., Kahn, B. B. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature (London) 409,729-733[Medline]



This article has been cited by other articles: